Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Sibley Memorial Hospital, Washington D.C., District of Columbia Johns Hopkins University/Johns Hopkins Hospital, Baltimore, Maryland Age range
18 Years and older
Last updated November 2024